Pursuant to Regulation 30 of the SEBI Listing Regulation, 2015, we wish to inform you that Praveg Limited has successfully completed the formal handover of operations of its flagship resort property, Praveg Atoll''s, located on Bangaram Island, Lakshadweep, to Indian Hotels Company Limited (IHCL). This handover is in accordance with the terms of the hotel management agreement executed between the two companies, as previously disclosed on March 3, 2025. A copy of the Press Release pertaining to this development is enclosed herewith.

pdf

Praveg Ltd.

23 Apr 2025

400.95

-0.25%

Company Update

Praveg Ltd - 531637 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

BSE India

Disclosure under Regulation 30 of SEBI Listing Regulations, the Board considered and approved the draft Scheme of Amalgamation between Eulogia Inn Private Limited (transferor Company) with Praveg Limited (Transferee Company).

pdf

Praveg Ltd.

23 Apr 2025

400.95

-0.25%

Company Update

Praveg Ltd - 531637 - Board Meeting Outcome for Revised Outcome Of Board Meeting Held Today

BSE India

Revised outcome of Board Meeting held on April 23, 2025

pdf

Praveg Ltd.

23 Apr 2025

400.95

-0.25%

Company Update

Praveg Ltd - 531637 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

BSE India

The Board of Directors considered and approved, in their meeting held today i.e. April 23, 2025, the draft scheme of amalgamation between Eulogia Inn Private Limited with Praveg Limited and their respective shareholders and creditors under section 230 to 232 of the Act

pdf

Praveg Ltd.

23 Apr 2025

400.95

-0.25%

Board Meeting

Praveg Ltd - 531637 - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, …

BSE India

In continuation of our intimation dated April 19, 2025 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at its meeting held on April 23, 2025 has inter alia, considered and approved: 1. To make an application for listing of existing paid up equity share capital of the company on the National Stock Exchange of India Limited (NSE); and 2. the draft Scheme of Amalgamation ('Scheme') between Eulogia Inn Private Limited (the Transferor Company) with Praveg Limited (the Transferee Company), and their respective shareholders and Creditors, under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ('the Act')

pdf

Praveg Ltd.

19 Apr 2025

400.95

-0.25%

Board Meeting

Praveg Ltd - 531637 - Board Meeting Intimation for Consideration And Approval Scheme Of Amalgamation

BSE India

Praveg Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/04/2025 ,inter alia, to consider and approve the Scheme of Amalgamation ('Scheme') between Eulogia Inn Private Limited (the Transferor Company) with Praveg Limited (the Transferee Company), and their respective shareholders and Creditors, under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ('the Act') and other applicable laws including the rules and regulations which envisages the amalgamation of Eulogia Inn Private Limited into and with Praveg Limited; ('Proposed Transaction'). Further to intimation dated March 27, 2025, relating to Closure of Trading Window, the Trading Window for dealing in securities of the Company shall remain closed till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter and year ended March 31, 2025.

pdf

Praveg Ltd.

04 Apr 2025

400.95

-0.25%

Company Update

Praveg Ltd - 531637 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Pursuant to Regulation 74(5) of the SEBI (DP) Regulations, 2018, please find enclosed a copy of the certificate for the quarter ended March 31, 2025 as received from the RTA of the company.

pdf

Praveg Ltd.

03 Apr 2025

400.95

-0.25%

Company Update

Praveg Ltd - 531637 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Clippings- Postal Ballot Notice

pdf

Is Sword & Shield Pharma Ltd. worth buying?

81 Votes:

Buy 74.07%

Sell 9.88%

Hold 16.05%